Related Experiment Videos
Andrea Marcellusi1, Aldo P Maggioni2, Anna L Mandorino3
1Dipartimento di Scienze Farmaceutiche, Università degli studi di Milano, Milano - Italy.
Global & Regional Health Technology Assessment
|February 18, 2026
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Closing the first wave of drug innovativeness in italy: final evidence from 2017 to 2025.
The European journal of health economics : HEPAC : health economics in prevention and care·2026
Extreme Cardiovascular Risk and LDL-C Target Achievement in People With HIV.
Open forum infectious diseases·2026
Impact of Ministerial Decree 77/2022 from different stakeholders' perspectives: clinicians, pharmacists, patients, and industry.
Global & regional health technology assessment·2026
Assessment and Appraisal of Drug Innovativeness in Italy: Ultimate Evidence on Key Drivers and Consistency.
Journal of market access & health policy·2026
Challenges and Perspectives in Optimising the Treatment of Arterial Hypertension: Role of the Ramipril-Amlodipine-Hydrochlorothiazide Single-Pill Combination.
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026
Integrating MCDA and economic evaluation into a rule-based framework for hospital-level health technology assessment.
Global & regional health technology assessment·2026
Burden of primary biliary cholangitis on the Italian National Health Service: retrospective analysis from an administrative database.
Global & regional health technology assessment·2026
Pharmacoeconomic analysis of switch to faricimab for neovascular age-related macular degeneration in real clinical practice.
Global & regional health technology assessment·2026
Impact of AIFA Note 100 on innovative antidiabetic prescribing eligibility in two Italian local health authorities: drug utilization and patient characteristics.
Global & regional health technology assessment·2026
Procedural activity and dynamics of the new Italian Scientific and Economic Committee (CSE): a one-year observational analysis.
Global & regional health technology assessment·2026
Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.
Journal of health services research & policy·2026
Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.
Health economics review·2026
Fever of unknown origin: cost of illness study.
Open medicine (Warsaw, Poland)·2026
The potential usefulness of health asset valuation to promote health among Korean employees.
Scientific reports·2026
Hospitalization costs and out-of-pocket expenses for stroke patients in mainland China.
BMC health services research·2026